OPK

Opko Health (OPK)

Opko Health Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:OPK

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/12/10	22:00	PR Newswire (US)	NextPlat Gains e-Commerce Access to Over 340 Million Consumers with Launch on JD.Com, China's Largest Online Retailer	NASDAQ:OPK	Opko Health Inc
2024/11/21	11:36	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:OPK	Opko Health Inc
2024/11/20	22:00	GlobeNewswire Inc.	OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference	NASDAQ:OPK	Opko Health Inc
2024/11/18	22:00	PR Newswire (US)	NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo	NASDAQ:OPK	Opko Health Inc
2024/11/14	20:00	PR Newswire (US)	NextPlat Reports $49.8 Million in Consolidated Revenue for the Nine Months Ended September 30, 2024, Representing a 136% Increase Over 2023 Results	NASDAQ:OPK	Opko Health Inc
2024/11/14	06:30	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:OPK	Opko Health Inc
2024/11/09	07:23	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:OPK	Opko Health Inc
2024/11/09	06:05	GlobeNewswire Inc.	Entera Bio Reports Q3 2024 Financial Results and Provides Business Updates	NASDAQ:OPK	Opko Health Inc
2024/11/08	06:12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OPK	Opko Health Inc
2024/11/08	06:05	GlobeNewswire Inc.	OPKO Health Reports Third Quarter 2024 Business Highlights and Financial Results	NASDAQ:OPK	Opko Health Inc
2024/11/07	22:00	GlobeNewswire Inc.	Aspira Women’s Health Expands Co-Marketing and Distribution Collaboration with BioReference® to Include OvaWatch®	NASDAQ:OPK	Opko Health Inc
2024/10/30	05:05	GlobeNewswire Inc.	OPKO Health to Report Third Quarter 2024 Financial Results on November 7, 2024	NASDAQ:OPK	Opko Health Inc
2024/10/07	21:00	PR Newswire (US)	NextPlat Secures Four-Year Extension of OPKO Healthcare E-Commerce Program in China and Agrees to the Expansion of the Program into Japan	NASDAQ:OPK	Opko Health Inc
2024/10/07	21:00	GlobeNewswire Inc.	ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program	NASDAQ:OPK	Opko Health Inc
2024/09/25	21:30	GlobeNewswire Inc.	Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic Disorders	NASDAQ:OPK	Opko Health Inc
2024/09/23	21:00	GlobeNewswire Inc.	OPKO Health’s ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical Development	NASDAQ:OPK	Opko Health Inc
2024/09/21	03:56	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:OPK	Opko Health Inc
2024/09/19	05:13	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:OPK	Opko Health Inc
2024/09/17	06:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OPK	Opko Health Inc
2024/09/16	20:30	PR Newswire (US)	Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health	NASDAQ:OPK	Opko Health Inc
2024/08/31	06:01	Edgar (US Regulatory)	Form DEFR14A - Revised definitive proxy soliciting materials	NASDAQ:OPK	Opko Health Inc
2024/08/24	06:33	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:OPK	Opko Health Inc
2024/08/20	06:23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OPK	Opko Health Inc
2024/08/15	05:50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OPK	Opko Health Inc
2024/08/13	07:27	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:OPK	Opko Health Inc
2024/08/10	05:05	GlobeNewswire Inc.	Entera Bio Reports Q2 2024 Financial Results and Provides Business Updates	NASDAQ:OPK	Opko Health Inc
2024/08/09	06:39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OPK	Opko Health Inc
2024/08/08	05:12	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:OPK	Opko Health Inc
2024/08/08	05:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OPK	Opko Health Inc
2024/08/08	05:06	GlobeNewswire Inc.	OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results	NASDAQ:OPK	Opko Health Inc